A5079239135- Animal Virus Infections Studies
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Vaccine Coverage and Hesitancy
University of Indonesia
2022
Facing the rising cases of with higher fatalities COVID-19, some countries decided to give third dose vaccine as a booster. As 9 January 2022, 90.31% health workers in Indonesia have received vaccine. This study aims provide an evaluation adverse events following immunization (AEFI) single center form basis for ensuring safety booster administration nationally. A retrospective, cross-sectional was conducted using online survey. Demographic data, AEFI complaints, and factors influencing AEFIs...
The longevity of vaccine effectiveness and antibody titer after the Moderna mRNA COVID-19 vaccination booster in healthcare workers Indonesia is not known.We performed a prospective observational study at Universitas Hospital vaccination. An Immunology Analyzer with Chemiluminescence Immunoassay (CLIA) test was used to examine Anti SARS-CoV-2 S-RBD levels. Antibody levels were classified into two systems (3 categories, 2 categories).There 31 male subjects (75.6%), 33 (80.5%) aged 25-39...